The effects of Implanon® on menstrual bleeding patterns

被引:163
作者
Mansour, Diana [2 ]
Korver, Tjeerd [1 ]
Marintcheva-Petrova, Maya [1 ]
Fraser, Ian S. [3 ]
机构
[1] Organon, Part Schering Plough Global Clin Dev, NL-5340 BH Oss, Netherlands
[2] Newcastle Gen Hosp, Graingerville Clin, Newcastle Contracept & Sexual Hlth Serv, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
[3] Univ Sydney, Dept Obstet & Gynaecol, Sydney, NSW 2006, Australia
关键词
Implanon (R); etonogestrel; contraception; irregular bleeding; dysmenorrhoea; discontinuation;
D O I
10.1080/13625180801959931
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives To evaluate an integrated analysis of bleeding patterns associated with use of the subdermal contraceptive implant Implanon (R) (etonogestrel, Organon, part of Schering-Plough) and to provide physician guidance to optimize patient counselling. Methods Data from 11 clinical trials were reviewed (N = 923). Assessments included bleeding-spotting records, dysmenorrhoea, and patient-perceived reasons for discontinuation. Bleeding patterns were analysed via reference period (RP) analyses. Results Implanon (R) use was associated with the following bleeding irregularities: amenorrhoea (22.2%) and infrequent (33.6%), frequent (6.7%), and/or prolonged bleeding (17.7%). In 75% of RPs, bleeding-spotting days were fewer than or comparable to those observed during the natural cycle, but they occurred at unpredictable intervals. The bleeding pattern experienced during the initial phase predicted future patterns for the majority of women. The group of women with favourable bleeding patterns during the first three months tended to continue with this pattern throughout the first two years of use, whereas the group with unfavourable initial patterns had at least a 50% chance that the pattern would improve. Only 11.3% of patients discontinued owing to bleeding irregularities, mainly because of prolonged flow and frequent irregular bleeding. Most women (77%) who had baseline dysmenorrhoea experienced complete resolution of symptoms. Conclusion Implanon (R) use is associated with an unpredictable bleeding pattern, which includes amenorrhoea and infrequent, frequent, and/or prolonged bleeding. The bleeding pattern experienced during the first three months is broadly predictive of future bleeding patterns for many women. Effective preinsertion counselling on the possible changes in bleeding patterns may improve continuation rates.
引用
收藏
页码:13 / 28
页数:16
相关论文
共 33 条
[1]   Tamoxifen treatment of bleeding irregularities associated with Norplant use [J].
Abdel-Aleem, H ;
Shaaban, OM ;
Amin, AF ;
Abdel-Aleem, AA .
CONTRACEPTION, 2005, 72 (06) :432-437
[2]  
Abdel-Aleem H, 2007, COCHRANE DATABASE SY
[3]   Hormonal treatment for bleeding irregularities in Norplant implant users [J].
AlvarezSanchez, F ;
Brache, V ;
Thevenin, F ;
Cochon, L ;
Faundes, A .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 174 (03) :919-922
[4]   LEVONORGESTREL-RELEASING AND COPPER-RELEASING (NOVA T) IUDS DURING 5 YEARS OF USE - A RANDOMIZED COMPARATIVE TRIAL [J].
ANDERSSON, K ;
ODLIND, V ;
RYBO, G .
CONTRACEPTION, 1994, 49 (01) :56-72
[5]  
[Anonymous], 2005, LONG ACT REV CONTR E
[6]   Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results [J].
Archer, David F. ;
Jensen, Jeffrey T. ;
Johnson, Julia V. ;
Borisute, Hannah ;
Grubb, Gary S. ;
Constantine, Ginger D. .
CONTRACEPTION, 2006, 74 (06) :439-445
[7]   THE ASSOCIATION BETWEEN VAGINAL BLEEDING PATTERNS AND REASONS FOR DISCONTINUATION OF CONTRACEPTIVE USE [J].
BELSEY, EM .
CONTRACEPTION, 1988, 38 (02) :207-225
[8]   THE ANALYSIS OF VAGINAL BLEEDING PATTERNS INDUCED BY FERTILITY REGULATING METHODS [J].
BELSEY, EM ;
MACHIN, D ;
DARCANGUES, C .
CONTRACEPTION, 1986, 34 (03) :253-260
[9]  
BELSEY EM, 1988, CONTRACEPTION, V38, P227, DOI 10.1016/0010-7824(88)90040-6
[10]   DETERMINANTS OF MENSTRUAL BLEEDING PATTERNS AMONG WOMEN USING NATURAL AND HORMONAL METHODS OF CONTRACEPTION .2. THE INFLUENCE OF INDIVIDUAL CHARACTERISTICS [J].
BELSEY, EM ;
DARCANGUES, C ;
CARLSON, N .
CONTRACEPTION, 1988, 38 (02) :243-257